| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.02B | $961.83M | $926.69M | $872.28M | $850.64M |
| R&D | – | – | – | – | – |
| SG&A | $65.28M | $61.65M | $60.72M | $58.71M | $56.51M |
| Operating Income | – | – | $1.16B | $1.12B | $1.68B |
| Interest Expense | $306.80M | $285.74M | $269.56M | $282.92M | $272.47M |
| Tax Expense | $1.58M | $1.26M | $1.15M | $900.00K | $915.00K |
| Net Income | $1.12B | $1.04B | $835.44M | $776.91M | $1.33B |
| EPS (basic) | 2.9500 | 2.7300 | 2.2000 | 2.0600 | 3.5600 |
| EPS (diluted) | 2.9400 | 2.7200 | 2.2000 | 2.0500 | 3.5400 |
| Shares (diluted) | $390.41M | $390.74M | $390.90M | $389.45M | $388.09M |